Neuroscience CRO Transpharmation is the largest boutique neuroscience specialised small and large animal CRO combining cross-species translational biology with world-class technology platforms. Opportunity: position as a partner for complex CNS translational programs requiring cross-species data to de-risk preclinical decisions.

Global Collaboration The company emphasizes flexible collaboration models including contract work or full-time capacity, and global service delivery. Opportunity: offer multi-region program support, co-development arrangements, and now with InterVivo Solutions, expand to joint ventures for broader geographic reach.

Accredited Validity Agenda Life Sciences holds AAALAC accreditation, underscoring robust scientific validity and reliable outcomes. Opportunity: leverage accreditation in proposals to biopharma sponsors seeking high-quality, animal welfare-compliant preclinical data.

EEG and Translational Recent partnerships and cross-species EEG analyses position Transpharmation as a leader in translational EEG paradigms aligned with clinical assets. Opportunity: present as the go-to CRO for preclinical EEG-driven endpoints and translational biomarkers for CNS therapeutics, including psychedelic and neuromodulation programs.

Strategic Partnerships Recent news highlights joint ventures with Cumulus Neuroscience and a data analysis service offering proprietary tremor analysis. Opportunity: target pharma sponsors needing integrated data analytics, cross-platform neurobehavioral readouts, and seamless handoff to first-in-human studies.